INNA-051 demonstrates accelerated viral clearance in an influenza challenge study, further supporting its prophylactic potential: new data revealed

Excited to share that portfolio company ENA Respiratory have just announced positive results from their Phase 2a influenza challenge study! This further supports the prophylactic potential of INNA-051 against complications associated with respiratory viral infections.

Well done team!

To read more on this announcement, head to